Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL – Get Rating) were down 6.4% on Thursday . The company traded as low as $2.18 and last traded at $2.19. Approximately 143,041 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 1,003,220 shares. The stock had previously closed at $2.34. Wall […]